Ovarian cancer-derived ascitic fluids induce a senescence-dependent pro-cancerogenic phenotype in normal peritoneal mesothelial cells

Malignant Peritoneal Mesothelioma: Characterization of the Inflammatory Response in the Tumor Microenvironment

(2015) Sean Judge et al.   ANNALS OF SURGICAL ONCOLOGY

Senescent peritoneal mesothelium induces a pro-angiogenic phenotype in ovarian cancer cells in vitro and in a mouse xenograft model in vivo

(2015) Justyna Mikuła-Pietrasik et al.   CLINICAL & EXPERIMENTAL METASTASIS

Metformin and epithelial ovarian cancer therapeutics

(2015) Seema Patel et al.   CELLULAR ONCOLOGY

Stromal Fibroblast in Age-Related Cancer: Role in Tumorigenesis and Potential as Novel Therapeutic Target

(2015) Abdelouahid Elkhattouti et al.   Frontiers in Oncology

HGF/c-Met axis drives cancer aggressiveness in the neo-adjuvant setting of ovarian cancer

(2015) Marisa Mariani et al.   Oncotarget

Specificity of cytochemical and fluorescence methods of senescence-associated β-galactosidase detection for ageing driven by replication and time

(2014) Patrycja Sosińska et al.   BIOGERONTOLOGY

Role of malignant ascites on human mesothelial cells and their gene expression profiles

(2014) Isabelle Matte et al.   BMC CANCER

Peritoneal mesothelium promotes the progression of ovarian cancer cells in vitro and in a mice xenograft model in vivo

(2014) Justyna Mikuła-Pietrasik et al.   CANCER LETTERS

Ovarian cancer ascites enhance the migration of patient-derived peritoneal mesothelial cellsviacMet pathway through HGF-dependent and -independent mechanisms

(2014) Isabelle Matte et al.   INTERNATIONAL JOURNAL OF CANCER

Mesothelial cells promote early ovarian cancer metastasis through fibronectin secretion

(2014) Hilary A. Kenny et al.   JOURNAL OF CLINICAL INVESTIGATION

2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) inhibits human ovarian cancer cell proliferation

(2014) Yan Li et al.   CELLULAR ONCOLOGY

Expression of H1.5 and PLZF in granulosa cell tumors and normal ovarian tissues: a short report

(2014) Mazdak Momeni et al.   CELLULAR ONCOLOGY

Mesothelial cell: A multifaceted model of aging

(2013) Krzysztof Książek   AGEING RESEARCH REVIEWS

Pseudomyxoma Peritonei: Inflammatory Responses in the Peritoneal Microenvironment

(2013) Kush Lohani et al.   ANNALS OF SURGICAL ONCOLOGY

Bystander senescence in human peritoneal mesothelium and fibroblasts is related to thrombospondin-1-dependent activation of transforming growth factor-β1

(2013) Justyna Mikuła-Pietrasik et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Evaluating cell lines as tumour models by comparison of genomic profiles

(2013) Silvia Domcke et al.   Nature Communications

Getting to Know Ovarian Cancer Ascites: Opportunities for Targeted Therapy-Based Translational Research

(2013) Nuzhat Ahmed et al.   Frontiers in Oncology

Resveratrol and its synthetic derivatives exert opposite effects on mesothelial cell-dependent angiogenesis via modulating secretion of VEGF and IL-8/CXCL8

(2012) Justyna Mikuła-Pietrasik et al.   ANGIOGENESIS

Senescent cells as a source of inflammatory factors for tumor progression

(2010) Albert R. Davalos et al.   CANCER AND METASTASIS REVIEWS

The chemokine CXCL1 induces proliferation in epithelial ovarian cancer cells by transactivation of the epidermal growth factor receptor

(2010) Christine Bolitho et al.   ENDOCRINE-RELATED CANCER

Senescent Peritoneal Mesothelial Cells Promote Ovarian Cancer Cell Adhesion

(2009) Krzysztof Ksiazek et al.   AMERICAN JOURNAL OF PATHOLOGY

History of the FIGO cancer staging system

(2008) Franco Odicino et al.   INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS